Cargando…
Adjuvant chemo-radiation for gastric adenocarcinoma: an institutional experience
BACKGROUND: Studies have shown that surgery alone is less than satisfactory in the management of early gastric cancer, with cure rates approaching 40%. The role of adjuvant therapy was indefinite until three large, randomized controlled trials showed the survival benefit of adjuvant therapy over sur...
Autores principales: | Aftimos, Philippe G, Nasr, Elie A, Nasr, Dolly I, Noun, Roger J, Nasr, Fady L, Ghosn, Marwan G, El Helou, Joelle A, Chahine, Georges Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887890/ https://www.ncbi.nlm.nih.gov/pubmed/20525367 http://dx.doi.org/10.1186/1748-717X-5-50 |
Ejemplares similares
-
Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature
por: Ghosn, Marwan, et al.
Publicado: (2016) -
Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma
por: Sakr, Riwa, et al.
Publicado: (2017) -
Laparoscopic Sleeve Gastrectomy for Mildly Obese Patients (Body Mass Index of 30 <35 kg/m(2)): Operative Outcome and Short-Term Results
por: Noun, Roger, et al.
Publicado: (2012) -
Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy
por: Kourie, Hampig Raphael, et al.
Publicado: (2015) -
Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey
por: Moujaess, Elissar, et al.
Publicado: (2021)